NEW YORK: Renalytix AI plc, an artificial intelligence-enabled in vitro diagnostics company, has received a clinical laboratory permit from the New York State Department of Health (NYS DOH) to provide commercial testing of KidneyIntelX. The permit was granted following an extensive review by a panel of NYS DOH scientists and external reviewers of the analytical…